Aims There are inconsistent results on the association between lipoprotein (a) and mortality-
related outcomes due to a lack of evidence from large-scale observational studies of Asians …

Background The concentrations of the highly atherogenic lipoprotein (a)[Lp (a)] are mainly
genetically determined by the LPA gene locus. However, up to 70% of the coding sequence …

Familial hypercholesterolaemia, familial combined hyperlipidaemia (FCH) and elevated
lipoprotein (a) are common, inherited disorders of apolipoprotein B metabolism that …

This review tells the story of atherosclerosis research in the beginning of the 20th century. It
presents the significance of cardiovascular diseases and addresses major questions …

Elevated lipoprotein (a) is a genetically transmitted codominant trait that is an independent
risk driver for cardiovascular disease. Lipoprotein (a) concentration is heavily influenced by …

Inflammation plays a crucial role in the pathogenesis of stroke. This study aims to determine
lipoprotein (a)[Lp (a)] levels in serum and to investigate their associations with stroke …

Abstract Purpose of Review The primary objective of this review is to explore the
pathophysiological roles and clinical implications of lipoprotein (a)[Lp (a)] in the context of …

Cardiovascular disease (CVD) is the leading cause of mortality in the modern world.
Traditional risk algorithms may miss up to 20% of CVD events. Therefore, there is a need for …

Clinicians are well aware of the importance of a positive family history for coronary artery
disease (CAD). Nonetheless, elucidation of the genetic basis of CAD has long proven …

Background—Genetic variation can be used to study causal relationships between
biomarkers and diseases. Here, we identify new common and rare genetic variants …